CSEA3 page news provides timely updates, authoritative reports, and thoughtful analysis on issues that shape our community and beyond. Stay informed with trusted coverage designed to keep members and partners engaged with the latest developments.
CSEA3 joined leading experts at FASIT 2025 in Kraków Poland
FASIT (Future of the Allergists and Allergen Specific Immunotherapy) is a company-sponsored scientific meeting bringing together leading experts, clinicians, and researchers to discuss advances in allergy and immunology. The programme focuses on allergen-specific immunotherapy, precision...
The CSEA3 participated in the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI) Congress 2025, held in Jakarta, Indonesia, from October 9–12, 2025
CSEA3’s active participation at APAAACI 2025 underscores its commitment to scientific excellence, international collaboration, and patient-centered innovation in allergy and asthma management....
Comparative Evaluation of an Allergen Exposure Chamber and Nasal Allergen Challenge Versus In-Field Symptom Assessment in Patients With Allergic Rhinitis Triggered by Timothy Grass Pollen
An allergen exposure chamber (AEC) is a specialized medical facility designed to expose individuals to allergens at precise and consistent concentrations within a controlled environment. This study aimed to correlate the assessment of clinical endpoints...
